Last updated: 2026-09-09 19:42:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Canopy Growth Corporation (CGC) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $0,96, with a market capitalization of $437,03M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,84 to $2,38. This page covers its latest market performance, valuation, price trends and company information.
$437,03M | |
$0,97 | |
$592,50 | |
$0,77 | |
$0,97 | |
1,48M | |
3,96M | |
-- | |
$2,38 | |
$0,84 | |
-- | |
-- |
Canopy Growth Corporation (CGC) is currently trading at $0,96 as of 2026-09-09 19:26:05, down 0,36% ($0,00) from the previous close of $0,97
During today's regular trading session, CGC has traded between $0,77 and $592,50, with a trading volume of 1,48M shares. The current price is near the lower end of today's range.
Over the past seven days, Canopy Growth Corporation (CGC) moved from $1,00 to $0,96, representing a decline of 3,75% ($0,04).
The stock traded between $0,95 and $1,02 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 2,26 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 7,7%
CGC is currently trading at $0,96, placing it 7,7% of the way from its 52-week low of $0,84 to its 52-week high of $2,38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 1128 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Canopy Growth Corporation (CGC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.